The issue of conflicts of interest has become more pressing as drug prices soar and health care companies reach out to the academic and policy community for advice.
In an interview last week, the FDAs Scott Gottlieb said the Orphan Drug Act of 1983 has provided an enormous amount of public health value over the years, but the market has changed.
The nations most influential science advisory group will tell Congress today that the U.S. pharmaceutical market is not sustainable and needs to change.
Earlier this month, House Republicans proposed eliminating the orphan drug tax credits, one of many financial incentives for drugmakers intended to spur development of medicines for rare diseases.
DebugScreen: mobile
{
"author": {
"name": "Sarah Jane Tribble Kaiser Health News",
"webUrl": "/author/profile/sarah-jane-tribble-kaiser-health-news/",
"description": "",
"imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
"estimate": 13,
"social": [],
"articles": [
{
"uri": "/2021/10/05/will-drug-price-reforms-make-it-through-congress/",
"title": "Will drug price reforms make it through Congress?",
"byline": "Sarah Jane Tribble, Kaiser Health News",
"kicker": "News",
"prettyDate": "October 05, 2021",
"timeToRead": "5 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2019/06/capitol-building-fotolia-clouds.jpg",
"width": "615",
"height": "395"
},
"authors": [
{
"webUrl": "/author/profile/sarah-jane-tribble-kaiser-health-news/",
"name": "Sarah Jane Tribble, Kaiser Health News"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "Democrats have not coalesced around any one plan as they seek to push through Congress a massive spending bill.",
"body": null
},
{
"uri": "/2020/09/04/hhs-takes-aim-at-rural-health-care-shortfalls-with-latest-plan/",
"title": "HHS takes aim at rural health care shortfalls with latest plan",
"byline": "Sarah Jane Tribble, Kaiser Health News",
"kicker": "News",
"prettyDate": "September 04, 2020",
"timeToRead": "5 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/05/FarmField.jpg",
"width": "0",
"height": "0"
},
"authors": [
{
"webUrl": "/author/profile/sarah-jane-tribble-kaiser-health-news/",
"name": "Sarah Jane Tribble, Kaiser Health News"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "The announcement comes in response to Trump's executive order last month calling for improved rural health and telehealth access.",
"body": null
},
{
"uri": "/2020/08/26/prognosis-for-rural-hospitals-worsens-with-pandemic/",
"title": "Prognosis for rural hospitals worsens with pandemic",
"byline": "Sarah Jane Tribble, Kaiser Health News",
"kicker": "Market Insights",
"prettyDate": "August 26, 2020",
"timeToRead": "6 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2019/07/HospitalClosedShutterstock.jpg",
"width": "616",
"height": "372"
},
"authors": [
{
"webUrl": "/author/profile/sarah-jane-tribble-kaiser-health-news/",
"name": "Sarah Jane Tribble, Kaiser Health News"
}
],
"kickerNode": [
{
"uri": "/market-insights/",
"sectionName": "Market Insights"
}
],
"summary": "As COVID-19 continues to spread, an increasing number of rural communities find themselves without their hospital.",
"body": null
},
{
"uri": "/2018/12/19/direct-reimbursement-an-overlooked-aid-for-expensi/",
"title": "Direct reimbursement: An overlooked aid for expensive prescriptions",
"byline": "Sarah Jane Tribble, Kaiser Health News",
"kicker": "Market Insights",
"prettyDate": "December 19, 2018",
"timeToRead": "6 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/12/MoneyExchanged.jpg",
"width": "616",
"height": "372"
},
"authors": [
{
"webUrl": "/author/profile/sarah-jane-tribble-kaiser-health-news/",
"name": "Sarah Jane Tribble, Kaiser Health News"
}
],
"kickerNode": [
{
"uri": "/market-insights/",
"sectionName": "Market Insights"
}
],
"summary": "When financial incentives like copay coupons and debit cards won't work, pharmaceutical companies sometimes will write a check.",
"body": null
},
{
"uri": "/2018/10/04/evergreening-and-other-ways-pharma-companies-manip/",
"title": "'Evergreening' and other ways pharma companies manipulate patents",
"byline": "Sarah Jane Tribble, Kaiser Health News",
"kicker": "Market Insights",
"prettyDate": "October 04, 2018",
"timeToRead": "6 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/03/PrescriptionDrugs.jpg",
"width": "600",
"height": "400"
},
"authors": [
{
"webUrl": "/author/profile/sarah-jane-tribble-kaiser-health-news/",
"name": "Sarah Jane Tribble, Kaiser Health News"
}
],
"kickerNode": [
{
"uri": "/market-insights/",
"sectionName": "Market Insights"
}
],
"summary": "The patenting of a small change in an existing drug is part of a tried-and-true strategy of enveloping products with a series of protective patents.",
"body": null
},
{
"uri": "/2018/07/27/pharma-giants-have-pledged-to-lower-prices-before/",
"title": "Pharma giants have pledged to lower prices before. Is this time different?",
"byline": "Jay Hancock, Kaiser Health News and Sarah Jane Tribble, Kaiser Health News",
"kicker": "Expert Opinion",
"prettyDate": "July 27, 2018",
"timeToRead": "1 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/05/05PriceDrugs.jpg",
"width": "616",
"height": "372"
},
"authors": [
{
"webUrl": "/author/profile/jay-hancock-kaiser-health-news/",
"name": "Jay Hancock, Kaiser Health News"
},
{
"webUrl": "/author/profile/sarah-jane-tribble-kaiser-health-news/",
"name": "Sarah Jane Tribble, Kaiser Health News"
}
],
"kickerNode": [
{
"uri": "/expert-opinion/",
"sectionName": "Expert Opinion"
}
],
"summary": "Promises by the pharmaceutical industry to contain prices are a familiar — and fleeting — phenomenon, say analysts.",
"body": null
},
{
"uri": "/2018/07/03/top-pharma-policy-expert-glosses-over-industry-con/",
"title": "Top pharma policy expert glosses over industry connections",
"byline": "Sarah Jane Tribble, Kaiser Health News",
"kicker": "Investigation",
"prettyDate": "July 03, 2018",
"timeToRead": "1 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/06/Mark-McClellan-BLOOMBERG.jpg",
"width": "616",
"height": "372"
},
"authors": [
{
"webUrl": "/author/profile/sarah-jane-tribble-kaiser-health-news/",
"name": "Sarah Jane Tribble, Kaiser Health News"
}
],
"kickerNode": [
{
"uri": "/investigation/",
"sectionName": "Investigation"
}
],
"summary": "The issue of conflicts of interest has become more pressing as drug prices soar and health care companies reach out to the academic and policy community for advice.",
"body": null
},
{
"uri": "/2017/12/28/fda-chief-open-to-rethinking-orphan-drug-incentive/",
"title": "FDA chief open to rethinking orphan-drug incentives",
"byline": " Sarah Jane Tribble, Kaiser Health News ",
"kicker": "",
"prettyDate": "December 28, 2017",
"timeToRead": "5 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/sarah-jane-tribble-kaiser-health-news/",
"name": "Sarah Jane Tribble, Kaiser Health News"
}
],
"kickerNode": [],
"summary": "In an interview last week, the FDAs Scott Gottlieb said the Orphan Drug Act of 1983 has provided an enormous amount of public health value over the years, but the market has changed.",
"body": null
},
{
"uri": "/2017/12/12/8-recommendations-to-cut-drug-prices-nationally/",
"title": "8 recommendations to cut drug prices nationally",
"byline": "Sarah Jane Tribble, Kaiser Health News",
"kicker": "",
"prettyDate": "December 12, 2017",
"timeToRead": "9 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/sarah-jane-tribble-kaiser-health-news/",
"name": "Sarah Jane Tribble, Kaiser Health News"
}
],
"kickerNode": [],
"summary": "The nations most influential science advisory group will tell Congress today that the U.S. pharmaceutical market is not sustainable and needs to change.",
"body": null
},
{
"uri": "/2017/12/01/orphan-drug-tax-credits-spark-showdown-between-pat/",
"title": "Orphan drug tax credits spark showdown between patients and Congress",
"byline": " Sarah Jane Tribble, Kaiser Health News ",
"kicker": "",
"prettyDate": "December 01, 2017",
"timeToRead": "7 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/sarah-jane-tribble-kaiser-health-news/",
"name": "Sarah Jane Tribble, Kaiser Health News"
}
],
"kickerNode": [],
"summary": "Earlier this month, House Republicans proposed eliminating the orphan drug tax credits, one of many financial incentives for drugmakers intended to spur development of medicines for rare diseases.",
"body": null
}
]
}
}
